EP Patent

EP3698775A1 — Topical antiviral compositions and methods of using the same

Assigned to Ligand Pharmaceuticals Inc · Expires 2020-08-26 · 6y expired

What this patent protects

The present invention relates generally to topical antiviral compositions for use in a method of treating and/or preventing a viral infection in a subject, and to topical compositions for use in a method of reducing the appearance and/or size of a lesion on a subject.

USPTO Abstract

The present invention relates generally to topical antiviral compositions for use in a method of treating and/or preventing a viral infection in a subject, and to topical compositions for use in a method of reducing the appearance and/or size of a lesion on a subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP3698775A1
Jurisdiction
EP
Classification
Expires
2020-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Ligand Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.